BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30076944)

  • 1. Factors Influencing Overall Survival of Children, Adolescents, and Young Adults With High-risk Renal Tumors.
    Islam M; Saltzman AF; Amini A; Carrasco A; Cost NG
    Urology; 2018 Oct; 120():222-230. PubMed ID: 30076944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Care and Survival Comparison of Adult and Pediatric Wilms Tumor in the United States: A Study of the National Cancer Database.
    Saltzman AF; Carrasco A; Amini A; Cost NG
    Urology; 2020 Jan; 135():50-56. PubMed ID: 31669270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric non-Wilms renal tumors: subtypes, survival, and prognostic indicators.
    Zhuge Y; Cheung MC; Yang R; Perez EA; Koniaris LG; Sola JE
    J Surg Res; 2010 Oct; 163(2):257-63. PubMed ID: 20538287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.
    Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y;
    Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of stage I anaplastic Wilms' tumour: a report from the Children's Oncology Group AREN0321 study.
    Daw NC; Chi YY; Kim Y; Mullen EA; Kalapurakal JA; Tian J; Khanna G; Geller JI; Perlman EJ; Ehrlich PF; Warwick AB; Grundy PE; Fernandez CV; Dome JS;
    Eur J Cancer; 2019 Sep; 118():58-66. PubMed ID: 31325873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical tactics in the treatment of malignant renal tumors in childhood.
    Pýcha K; Snajdauf J; Koutecký J; Kodet R; Zítková M
    Pediatr Surg Int; 1997 Feb; 12(2-3):145-7. PubMed ID: 9156843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group.
    Furtwängler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
    Eur J Cancer; 2013 Nov; 49(16):3497-506. PubMed ID: 23880476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant renal tumors in childhood: report of 54 cases treated at a single institution.
    Jaing TH; Hung IJ; Yang CP; Lai JY; Tseng CK; Chang TY; Hsueh C; Tsay PK
    Pediatr Neonatol; 2014 Jun; 55(3):175-80. PubMed ID: 24279977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of lymph node sampling and the impact of lymph node density in favorable histology Wilms tumor: An analysis of the national cancer database.
    Saltzman AF; Carrasco A; Amini A; Aldrink JH; Dasgupta R; Gow KW; Glick RD; Ehrlich PF; Cost NG
    J Pediatr Urol; 2018 Apr; 14(2):161.e1-161.e8. PubMed ID: 29133167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.
    Grundy RG; Hutton C; Middleton H; Imeson J; Pritchard J; Kelsey A; Marsden HB; Vujanic GM; Taylor RE;
    Pediatr Blood Cancer; 2004 Apr; 42(4):311-9. PubMed ID: 14966826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of patients with revised stage I clear cell sarcoma of kidney treated in National Wilms Tumor Studies 1-5.
    Kalapurakal JA; Perlman EJ; Seibel NL; Ritchey M; Dome JS; Grundy PE
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):428-31. PubMed ID: 22658515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
    Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell sarcoma of the kidney: patients' characteristics and improved outcome in developing countries.
    Zekri W; Alfaar AS; Yehia D; Elshafie MM; Zaghloul MS; El-Kinaai N; Taha H; Refaat A; Younes AA
    Pediatr Blood Cancer; 2014 Dec; 61(12):2185-90. PubMed ID: 25175045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathology of uncommon malignant renal neoplasms in the pediatric age group.
    Radhika S; Bakshi A; Rajwanshi A; Nijhawan R; Das A; Kakkar N; Joshi K; Marwaha RK; Rao KL
    Diagn Cytopathol; 2005 May; 32(5):281-6. PubMed ID: 15830360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.
    Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ
    J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 20-year prospective study of Wilms tumor and other kidney tumors: a report from Hong Kong pediatric hematology and oncology study group.
    Chan CC; To KF; Yuen HL; Shing Chiang AK; Ling SC; Li CH; Cheuk DK; Li CK; Shing MM
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):445-50. PubMed ID: 25050908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.
    Cai W; Liu X; Ge W; Wu D; Xu J; Bai R; Hu H
    Int J Med Sci; 2021; 18(4):911-920. PubMed ID: 33456348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.